Korean Journal of Food Science and Technology (한국식품과학회지)

Korean Society of Food Science and Technology (한국식품과학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of curcumin on human health - A reassessment

커큐민이 건강에 미치는 효과 - 재평가

  • Kim, Dae-Ok (Department of Food Science and Biotechnology, Kyung Hee University) ;
  • Lee, Chang Y. (Department of Food Science, Cornell University)
  • Received : 2021.08.18
  • Accepted : 2021.09.13
  • Published : 2021.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Curcumin is known to possess diverse beneficial physiological effects including antioxidant, anti-inflammatory, anti-depressant, anti-microbial, and anti-neoplastic activities, as well as immune-modulating, metabolism-regulating, and neuroprotective effects. However, despite more than 13,000 research papers published during the last ten years regarding the health benefits of curcumin, curcumin has not been introduced in the market as a pharmaceutical agent in any country. Despite the abundance of positive findings, most investigations that tout its health benefits are based on in vitro and in vivo studies that fail to consider the protean chemical behaviors of curcumin, which is known to be a pan-assay interference compound and an invalid metabolic panacea. Therefore, human clinical trials, despite rigorous study design, have been unable to prove specific benefits. This article reviews the pleiotropic properties of curcumin so that they can be balanced against its beneficial effects and suggests potential research avenues to better understand its health benefits.

커큐민은 산화방지능, 항염증, 항우울, 항균, 항종양 등의 다양하고 유익한 생리학적 활성이 있는 것으로 알려져 있다. 또한, 커큐민은 면역조절, 대사조절, 신경보호 효과도 가지고 있다. 지난 10년 동안 13,000편 이상의 연구 논문에서 커큐민의 건강상 이점에 대한 연구가 발표되었음에도 불구하고, 아직까지 전 세계 어느 나라에서도 커큐민을 의약품으로 시장에 출시하지 못하고 있다. 긍정적인 결과가 많음에도, 건강상의 이점을 내세우는 대부분의 연구는 커큐민의 다양한 화학적 거동을 고려하지 않은 시험관실험 및 동물실험에 기반으로 하고 있다. 커큐민은 PAINS이자 IMPs 중의 하나로 알려져 있다. 따라서 엄격한 연구 설계에도 불구하고, 인체적용시험 및 임상시험은 특별한 이점을 입증할 수 없었다. 이 논문에서는 커큐민의 다면적 특성을 검토하여 커큐민의 부정적 특성이 이로운 효과와 균형을 이룰 수 있도록 하고 건강상의 이점을 더 잘 이해할 수 있는 잠재적 연구 방법을 제안하고 있다.

Keywords

References

  1. Baell J, Walters MA. Chemical con artists foil drug discovery. Nature 513: 481-483 (2014) https://doi.org/10.1038/513481a
  2. Baker M. Chemists warn against deceptive molecules. Nature 541: 144-145 (2017) https://doi.org/10.1038/541144a
  3. Bisson J, McAlpine JB, Friesen JB, Chen S-N, Graham J, Pauli GF. Can invalid bioactives undermine natural product-based drug discovery? J. Med. Chem. 59: 1671-1690 (2016) https://doi.org/10.1021/acs.jmedchem.5b01009
  4. Burgos-Moron E, Calderon-Montano JM, Salvador J, Robles A, Lopez-Lazaro M. The dark side of curcumin. Int. J. Cancer 126: 1771-1775 (2010) https://doi.org/10.1002/ijc.24967
  5. Calabrese EJ, Kozumbo WJ. The hormetic dose-response mechanism: Nrf2 activation. Pharmacol. Res. 167: 105526 (2021) https://doi.org/10.1016/j.phrs.2021.105526
  6. Cas MD, Ghidoni R. Dietary curcumin: correlation between bioavailability and health potential. Nutrients 11: 2147 (2019) https://doi.org/10.3390/nu11092147
  7. Dahlin JL, Nissink JWM, Strasser JM, Francis S, Higgins L, Zhou H, Zhang Z, Walters MA. PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS. J. Med. Chem. 58: 2091-2113 (2015) https://doi.org/10.1021/jm5019093
  8. EFSA FEEDAP Panel (EFSA Panel on Additives and Products or Substances used in Animal Feed), Bampidis V, Azimonti G, de Lourdes Bastos M, Christensen H, Durjava MK, Kouba M, Lopez-Alonso M, Puente SL, Marcon F, Mayo B, Pechova A, Petkova M, Ramos e, Sanz Y, Villa RE, Woutersen R, Brantom P, Chesson A, Westendorf J, Gregoretti L, Manini P, Dusemund B. Safety and efficacy of turmeric extract, turmeric oil, turmeric oleoresin and turmeric tincture from Curcuma longa L. rhizome when used as sensory additives in feed for all animal species. EFSA J. 18: 6146 (2020)
  9. Giridhar K. Curcumin: Can it slow cancer growth? Available from: https://www.mayoclinic.org/diseases-conditions/cancer/expert-answers/curcumin/faq-20057858. Accessed Feb. 27, 2021. (2020)
  10. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 15: 195-218 (2013) https://doi.org/10.1208/s12248-012-9432-8
  11. Gupta SC, Prasad S, Kim JH, Patchva S, Webb LJ, Priyadarsini IK, Aggarwal BB. Multitargeting by curcumin as revealed by molecular interaction studies. Nat. Prod. Rep. 28: 1937-1955 (2011) https://doi.org/10.1039/c1np00051a
  12. Heger M, van Golen RF, Broekgaarden M, Michel MC. The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin and its metabolites in relation to cancers. Pharmacol. Rev. 68: 222-307 (2014)
  13. Hewlings SJ, Kalman DS. Curcumin: a review of its effects on human health. Foods 6: 92 (2017) https://doi.org/10.3390/foods6100092
  14. Ireson C, Orr S, Jones DJL, Verschoyle R, Lim C-K, Luo J-L, Howells L, Plummer S, Jukes R, Williams M, Steward WP, Gescher A. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res. 61: 1058-1064 (2001)
  15. Ireson CR, Jones DJL, Orr S, Coughtrie MWH, Boocock DJ, Williams ML, Farmer PB, Steward WP, Gescher AJ. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol. Biomark. Prev. 11: 105-111 (2002)
  16. Jamwal R. Bioavailable curcumin formulations: a review of pharmacokinetic studies in healthy volunteers. J. Integr. Med. 16: 367-374 (2018) https://doi.org/10.1016/j.joim.2018.07.001
  17. Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hashiguchi M, Tsujiko K, Matsumoto S, Ishiguro H, Chiba T. Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer Chemother. Pharmacol. 69: 65-70 (2012) https://doi.org/10.1007/s00280-011-1673-1
  18. Kanai M, Otsuka Y, Otsuka K, Sato M, Nishimura T, Mori Y, Kawaguchi M, Hatano E, Kodama Y, Matsumoto S, Murakami Y, Imaizumi A, Chiba T, Nishihira J, Shibata H. A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients. Cancer Chemother. Pharmacol. 71: 1521-1530 (2013) https://doi.org/10.1007/s00280-013-2151-8
  19. Manolova Y, Deneva V, Antonov L, Drakalska E, Momekova D, Lambov N. The effect of the water on the curcumin tautomerism: a quantitative approach. Spectrochim. Acta A Mol. Biomol. Spectrosc. 132: 815-820 (2014) https://doi.org/10.1016/j.saa.2014.05.096
  20. Metzler M, Pfeiffer E, Schulz SI, Dempe JS. Curcumin uptake and metabolism. BioFactors 39: 14-20 (2013) https://doi.org/10.1002/biof.1042
  21. Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The essential medicinal chemistry of curcumin. J. Med. Chem. 60: 1620-1637 (2017) https://doi.org/10.1021/acs.jmedchem.6b00975
  22. Pandey A, Chaturvedi M, Mishra S, Kumar P, Somvanshi P, Chaturvedi R. Reductive metabolites of curcumin and their therapeutic effects. Heliyon 6: e05469 (2020) https://doi.org/10.1016/j.heliyon.2020.e05469
  23. Pluta R, Januszewski S, Ulamek-Koziol M. Mutual two-way interactions of curcuminc and gut microbiota. Int. J. Mol. Sci. 21: 1055 (2020) https://doi.org/10.3390/ijms21031055
  24. Priyadarsini KI. The chemistry of curcumin: from extraction to therapeutic agent. Molecules 19: 20091-20112 (2014) https://doi.org/10.3390/molecules191220091
  25. Pulido-Moran M, Moreno-Fernandez J, Ramirez-Tortosa C, RamirezTortosa M. Curcumin and health. Molecules 21: 264 (2016) https://doi.org/10.3390/molecules21030264
  26. Purpura M, Lowery RP, Wilson JM, Mannan H, Munch G, Razmovski-Naumovski V. Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects. Eur. J. Nutr. 57: 929-938 (2018) https://doi.org/10.1007/s00394-016-1376-9
  27. Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, Wada H, Katanasaka Y, Kakeya H, Fujita M, Hasegawa K, Morimoto T. Innovative preparation of curcumin for improved oral bioavailability. Biol. Pharm. Bull. 34: 660-665 (2011) https://doi.org/10.1248/bpb.34.660
  28. Smith T, Kawa K, Eckl V, Morton C, Stredney R. Herbal supplement sales in US increased 8.5% in 2017, topping $8 billion. Herbal-Gram 119: 62-71 (2018)
  29. Stohs SJ, Chen O, Ray SD, Ji J, Bucci LR, Preuss HG. Highly bioavailable forms of curcumin and promising avenues for curcumin-based research and application: a review. Molecules 25: 1397 (2020) https://doi.org/10.3390/molecules25061397
  30. Stohs SJ, Ji J, Bucci LR, Preuss HG. A comparative pharmacokinetic assessment of a novel highly bioavailable curcumin formulation with 95% curcumin: a randomized, double-blind, crossover study. J. Am. Coll. Nutr. 37: 51-59 (2019) https://doi.org/10.1080/07315724.2017.1358118
  31. Subhan F, Khalil AAK, Bhatti MZ, Haider A, Tauseef I, Haleem SK, Ibrahim AS. Curcumin: from ancient spice to modern anti-viral drug in COVID-19 pandemic. Life Sci. 1(suppl): 69-73 (2020)
  32. Syng-ai C, Kumari AL, Khar A. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol. Cancer Ther. 3: 1101-1108 (2004) https://doi.org/10.1158/1535-7163.1101.3.9
  33. Thurston DE, Pysz I. Chemopreventive Agents. In: Chemistry and Pharmacology of Anticancer Drugs. 2nd ed., pp. 529-578. CRC Press Inc., Boca Raton, FL, USA (2021)
  34. U.S. Food and Drug Administration. 187 Fake Cancer 'Cures' Consumers Should Avoid. (https://web.archive.org/web/20170502034227/ https://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/enforcementactivitiesbyfda/ucm171057.htm) Archived from original on May 2, 2017. Retrieved August 11, 2021. (2017)
  35. Um MY, Yoon M, Lee J, Jung J, Cho S. A novel potent sleep-promoting effect of turmeric: turmeric increases non-rapid eye movement sleep in mice via histamine H1 receptor blockade. Mol. Nutr. Food Res. 65: 2100100 (2021) https://doi.org/10.1002/mnfr.202100100
  36. Vareed SK, Kakarala M, Ruffin MT, Crowell JA, Normolle DP, Djuric Z, Brenner DE. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol. Biomark. Prev. 17: 1411-1417 (2008) https://doi.org/10.1158/1055-9965.EPI-07-2693
  37. Wang Y-J, Pan M-H, Cheng A-L, Lin L-I, Ho Y-S, Hsieh C-Y, Lin J-K. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 15: 1867-1876 (1997) https://doi.org/10.1016/S0731-7085(96)02024-9
  38. Woo J-H, Park J-M, Jang J-H, Yang H, Surh Y-J, Na H-K. Curcumin induces expression of 15-hydroxyprostaglandin dehydrogenase in gastric mucosal cells and mouse stomach in vivo: AP-1 as a potential target. J. Nutr. Biochem. 85: 108469 (2020) https://doi.org/10.1016/j.jnutbio.2020.108469
  39. Yang K-Y, Lin L-C, Tseng T-Y, Wang S-C, Tsai T-H. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J. Chromatogr. B 853: 183-189 (2007) https://doi.org/10.1016/j.jchromb.2007.03.010
  40. Yeung AWK, Horbanczuk M, Tzvetkov NT, Mocan A, Carradori S, Maggi F, Marchewka J, Sut S, Dall'Acqua S, Gan R-Y, Tancheva LP, Polgar T, Berindan-Neagoe I, Pirgozliev V, Smejkal K, Atanasov AG. Curcumin: total-scale analysis of the scientific literature. Molecules 24: 1393 (2019) https://doi.org/10.3390/molecules24071393